<DOC>
	<DOC>NCT01099839</DOC>
	<brief_summary>This study is to assess the pharmacokinetic interaction between ASP1941 and Miglitol in healthy volunteers.</brief_summary>
	<brief_title>A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol</brief_title>
	<detailed_description>This will be a randomized, open-label, 3-way crossover design study to assess the drug-drug interaction between a single oral dose of ASP1941 and a single oral dose of Miglitol in healthy adult male volunteers. Each subject will receive "ASP1941 alone", "Miglitol alone" and "ASP1941 + Miglitol".</detailed_description>
	<mesh_term>Miglitol</mesh_term>
	<mesh_term>1-Deoxynojirimycin</mesh_term>
	<criteria>Healthy as judged by the investigator/subinvestigator based on the results of physical examinations and laboratory tests Body weight ; ≥50.0 kg, &lt;80.0 kg Body Mass Index ; ≥17.6, &lt;26.4 Written informed consent has been obtained Received any investigational drugs within 120 days before the screening assessment Donated 400 mL of whole blood within 90 days, 200 mL of whole blood within 30 days, or blood components within 14 days before the screening assessment Received medication within 7 days before hospital admission A deviation from the assessment criteria of physical examinations or laboratory tests at screening or upon admission History of drug allergies With renal, hepatic, gastrointestinal, heart, cerebrovascular or respiratory diseases Previous treatment with ASP1941</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Miglitol</keyword>
</DOC>